As of 1:30 PM on the 2nd, Komipharm is trading at 12,650 KRW, up 1.2% from the previous day. This is a 19.43% decrease compared to October 6. Komipharm is known as a manufacturer of veterinary vaccines and disinfectants.

Today, foreigners are tentatively recorded as net buyers of 11,168 shares. Over the past five days, individual investors have been net sellers of 71,933 shares, while foreigners and institutions have been net buyers of 3,269 shares and 76,453 shares, respectively.


On October 27, Komipharm became an issue in the market with the headline, "New drug 'Kominox anticancer effect' confirmed?... Stock price rebounds."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing